Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma

Objective. To evaluate the efficacy and safety of docetaxel plus oxaliplatin and capecitabine (DOX) in the first line treatment of advanced gastric adenocarcinoma. Methods. A total of 37 patients were enrolled into this study, and they received DOX regimen (docetaxel 75 mg/m(2) and oxaliplatin 130 m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Liu, Ying, Ye, Zhengbao, Xi, Wenqi, Ma, Tao, Shi, Min, Yang, Liu, Zhu, Zhenggang, Zhang, Jun
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2013
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787590/
https://ncbi.nlm.nih.gov/pubmed/24151630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/971096
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares